A common artificial sweetener may trigger insulin spikes that lead to the build up of fatty plaques in the arteries, ...

An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

Sotagliflozin significantly reduces heart attacks and strokes in high-risk patients with diabetes and kidney disease, offering a new treatment option for cardiovascular protection. Sotagliflozin, a re ...

A new study found that a drug recently approved to treat type 2 diabetes and kidney disease in patients with additional ...

Can telemedicine and exercise apps improve the health of people with type 2 diabetes and coronary heart disease? A large ...

Discover how this diabetes drug is revolutionizing heart health. Learn about its surprising benefits in reducing cardiovascular risks and mortality.

Type 1 diabetics have a lower risk of experiencing a cardiovascular event such as a stroke or heart attack than type 2 diabetics, a new study has found. It highlights the fundamental difference ...

A new study has found a medication already used to treat people who have type 2 diabetes and/or chronic kidney disease with added heart disease risks also helps lower their stroke and heart attack ...

While conducting the study, the researchers tracked data from more than 10,000 patients who presented with type 2 diabetes, ...

More than 830 million people worldwide have diabetes—a chronic, debilitating disease. But experts say it’s possible to recover with a few proven lifestyle changes.

Blood pressure. Having both diabetes and high blood pressure dramatically increases heart disease risk. Triglycerides and low ...